Image
TOKYO - The Japanese unit of Britain's Jazz Pharmaceuticals PLC (JAZZ.O) said on Thursday it had started a phase III trial of a cannabis-based drug for epilepsy. The trial follows a recommendation by a health ministry panel in September to revise Japan's drug laws to allow for the importation and